FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/07/071531 [Registered on: 30/07/2024] Trial Registered Prospectively
Last Modified On: 25/07/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Effect of hingvadi churna in post delivery backache: A clinical study 
Scientific Title of Study   A randomised controlled clinical trial to study the effect of hingvadi churna in katishula with special reference to sutika roga .  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Vama Hitesh Sanghvi  
Designation  PG Student  
Affiliation  SMBT Ayurved college and hospital 
Address  Department of Prasuti Tantra Evum Stri Roga SMBT Ayurved College and Hospital Dhamangaon Nashik Nashik Maharashtra 422403 India

Nashik
MAHARASHTRA
422403
India 
Phone  9773559985  
Fax    
Email  vamasanghvi110@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sameer S Gholap  
Designation  Professor  
Affiliation  SMBT Ayurved college and hospital  
Address  Department of Prasuti Tantra Evum Stri Roga SMBT Ayurved college and hospital Dhamangaon Nashik Nashik Maharashtra 422403 India

Nashik
MAHARASHTRA
422403
India 
Phone  9820304881  
Fax    
Email  drsameer.gholap@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sameer S Gholap  
Designation  Professor  
Affiliation  SMBT Ayurved college and hospital  
Address  Department of Prasuti Tantra Evum Stri Roga SMBT Ayurved college and hospital Dhamangaon Nashik Nashik Maharashtra 422403 India

Nashik
MAHARASHTRA
422403
India 
Phone  9820304881  
Fax    
Email  drsameer.gholap@gmail.com  
 
Source of Monetary or Material Support  
Department of Prasuti Tantra Evum Stri Roga SMBT ayurved college and hospital Nandi hills igatpuri dhamangaon nashik 422403 Nashik Maharashtra India  
 
Primary Sponsor  
Name  Dr Vama Hitesh Sanghvi  
Address  Department of Prasuti Tantra Evum Stri Roga SMBT Ayurved college and Hospital Dhamangaon Nashik Nashik 422403 Maharashtra India  
Type of Sponsor  Other [Self ] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Vama Hitesh Sanghvi   SMBT ayurved hospital  OPD no 04 Department of Prasuti Tantra evum Stri roga
Nashik
MAHARASHTRA 
9773559985

vamasanghvi110@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
SMBT ayurved college and hospital   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:O909||Complication of the puerperium, unspecified. Ayurveda Condition: SUTIKAROGAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Hingvadi churna , Reference: Bhaisajya ratnavali, Route: Oral, Dosage Form: Churna/ Powder, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 14 Days, anupAna/sahapAna: Yes(details: -koshnajal), Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: Chaturbeej churna, Reference: Bhavprakash nighantu, Route: Oral, Dosage Form: Churna/ Powder, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 14 Days, anupAna/sahapAna: Yes(details: -koshnajal), Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  35.00 Year(s)
Gender  Female 
Details  The signs and the Symptoms of puerperal women after normal delivery
Full-term normal delivery irrespective of parity and gravida
Married women.
Patients between 18 -35 years of age.
Patient willing to give written consent
 
 
ExclusionCriteria 
Details  L.S.C.S.
Previous operations
Patients with known case of Spine disorders
Patients with Any previous surgeries/ lumbar / abdominal surgery
Patients unwilling to give informed written consent.
Age group below 18 years and above 35 years.
High-risk pregnancies associated with known case of PIH, Pre- Eclampsia, Eclampsia, PPH, CPD.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Centralized 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To assess the effect of hingvadi churna in katishula with special reference to sutika roga with the help of assessment criteria after 14 days of treatment  Reduction in signs and symptoms of katishula in sutika after 14 days of treatment  
 
Secondary Outcome  
Outcome  TimePoints 
To study effectiveness of trial and control group   18 months 
 
Target Sample Size   Total Sample Size="70"
Sample Size from India="70" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   05/08/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Womens health is crucial not only for the individual but also for the society. In
today’s society, postpartum women face various health issues due to lifestyle
changes, stress, and strain Many mothers complain of physical problems like back
pain and joint pain after delivery. Sutika katishula is commonest condition. It can be a cause of many Abnormal dietics or lifestyle or because of improper garbhini paricharya or sutika paricharya. The prevalence rate of sutika katishula is 33.33%.In modern science, treatment of katishula is analgesics which subside the pain temporarily and causes side effect if used for a longer period of time as well as affects
baby through breast feeding. In ayurveda the main aim is vatahara which in turn ( pacifies the vata) and
increasing the agni. Line of treatment is vatahara and agnidipana. Hingavadi churna has same properties. The contents of this drug are easily available and cost effective and has more efficient properties to cure sutika katishula. The clinical study of Hingavadi churna has not been yet accessed in sutika katishula so it will help to fill knowledge gap. Study includes the female patient having sign and symptoms of sutika katishula between age group of 18-35 year who fulfill terms of inclusion criteria. Written consent is taken from patient to ensure ethical compliance and transparency in research process. Total Sample size is 70 and is calculated by using Daniel 1999 formula. 35 patients in each group. Simple random sampling technique will be used. Total number of patients is 70 which is divided into two groups named as Group A ( trial group) and group B ( control group). Hingvadi churna is given to group A ( Trial group ) and chaturbeej churna is given to group B ( control group). Drugs will be purchased from GMP certified pharmacy. Both drugs will be administered for 14 days. All SOP of churna preparation will be followed throughout the clinical trial. Observation will be done on 0th day, 7th day and 14th day. Scale used for assessment will be Oswestry Disability Index scale. Results will be drawn on the basis of assessment criteria and Statistical analysis.Discussion will be carried out on the basis of observation and result obtained during treatment. Summary will be drawn and the thesis work will be summarized with the help of statistical analysis. Conclusion will be drawn out.
 
Close